Since circFat1 KD attenuated STAT3 activation and SOX2 expression, we further examined whether circFat1 KD could enhance PD1 blockade‐mediated immunotherapy of HNSCC by activating tumor cell intrinsic type 1 IFN signaling. The gene discussed is SOX2; the disease is head and neck squamous cell carcinoma.